The investment objective of Invesco India Pharma And Healthcare Fund Direct (G) is the scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in pharmaceuticals, healthcare and allied sectors.
Invesco India Pharma And Healthcare Fund Direct (G) is very high.
The new fund offer (NFO) period for Invesco India Pharma And Healthcare Fund Direct (G) is 2026-09-07 to 2026-09-01 with minimum investment amount of ₹ 5,000
Invesco India Pharma And Healthcare Fund Direct (G) NFO Details
NFO Open Date
-
Offer Close
01 Sep, 2026
Unit Price
₹ 10
Min. Amount
₹ 5,000
Entry Load
Not Applicable
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Scheme Type
Equity
Fund Option
Invesco India Pharma And Healthcare Fund Direct (G)
Invesco entered India in 2013. In partnership with Religare Securities Ltd. it formed Religare Invesco Asset Management Co. Ltd. Religare Invesco Mutual Fund was co-owned by Invesco and Religare.
